Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Mood Disorders

• Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
• The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)
• Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
• Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
• Synaptic Imaging and Network Activity in Treatment Resistant Depression
• EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders
• Gut Microbiota in Mood Disorders in Lebanese Population
• Chinese Longitudinal and Systematic Study of Bioplar Disorder
• The Role of Ketamine and Dexmedetomidine in Opioid-Sparing Analgesia
• Pramipexole for Anhedonic Depression
• Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
• Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control
• D-serine AudRem: R33 Phase
• Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
• Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder
• Relative Bioavailability of LY03010 Compared to Listed Drug
• Acetazolamide for Treatment Resistant Schizophrenia
• Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model
• Brief Group Psychotherapy for Anxiety and Depression
• Brief Psychotherapies for Emotional Disorders in Primary and Secondary Care
• Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)
• Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement
• Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
• Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder
• EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders
• Bazedoxifene -Treatment for Women With Schizophrenia
• Ketamine for Mood Disorders With Suicidal Ideation
• L-arginine Study for Persistent Symptoms of Schizophrenia
• Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
• Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
• Brain Insulin Resistance in Mood Disorders
• A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth
• Telmisartan Pilot Study on Treatment Resistant Schizophrenia
• Effects of Acute Prucalopride Administration in Healthy Volunteers
• Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
• Cromoglycate Adjunctive Therapy for Outpatients With Schizophrenia
• A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients
• Vitamin D Supplementation and Effects on Mood in Emergency Medicine Residents
• Nitrous Oxide- Suicidal Ideation
• D-serine Augmentation of Neuroplasticity
• Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced Mood Symptoms in Women With Past Perimenopausal Depression
• Cognitive Effects of Nimodipine in Patients With Schizophrenia
• Effects of Seven Day Prucalopride Administration in Healthy Volunteers
• A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
• Cannabidiol as an Adjunctive Treatment for Bipolar Depression
• Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
• Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders
• A Clinical Trial of Intravenous Ganaxolone in Women With Postpartum Depression
• Levetiracetam in Early Psychosis
• Cost- Effectiveness and Quality of Life Assessment in Mood Disorder
• Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
• Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
• Imaging SV2A in Mood Disorders
• Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression
• Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
• Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
• Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial
• Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
• Effects of Metformin and Fish Oil on Treatment With Clozapine
• Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study
• Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts.
• Lithium for Suicidal Behavior in Mood Disorders
• Treating Emotional Disorders in Primary Care With Psychological Techniques
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
• A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
• Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
• Pioglitazone in Patients With Mood Disorders
• The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff
• Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia
• Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)
• Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
• Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
• Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)
• Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
• Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms
• Multidimensional Measurement of Psychopharmacological Treatment Response
• Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)
• Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)
• Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder
• Quetiapine Augmentation for Primary Anxiety Disorder or Mood Disorders With Co-morbid Anxiety Symptoms
• Functional MRI Before and After Treatment for Depression
• Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)
• Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)
• Treatment of Psychotic Major Depression With Mifepristone
• Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
• A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
• Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers
• Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
• Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?
• A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder
• An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder
• Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder
• Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
• Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia
• Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders
• Prevention of Mood Disorders by Folic Acid Supplementation
• Cannabinoids in Bipolar Affective Disorder
• Efficacy of Sleep Interventions for Posttraumatic Stress Disorder (PTSD)
• Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
• Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
• Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
• A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
• A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder
• PET Neuroimaging of [11C]Mirtazapine
• Study of Amantadine for Weight Stabilization During Olanzapine Treatment
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
• Integrated Treatment for Cocaine and Mood Disorders - 1
• A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
• Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings
• Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER
• Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?
• Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
• Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness
• Dynamic Measures of Neurochemistry in Mood Disorders
• Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
• Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1
• Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
• Rapid Antidepressant Effects of Ketamine in Major Depression
• Dutasteride to Treat Women With Menstrually Related Mood Disorders
• Seasonal Affective Depression (SAD) Study
• Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies
• Prevention of Seasonal Affective Disorder
• Prevention of Seasonal Affective Disorder
• A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
• Clinical Trial of Propranolol for Seasonal Affective Disorder
• Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects
• Treatment of Mid-Life-Related Mood Disorders
• New Drugs in the Treatment of Mood Disorders
• The Role of Hormones in Postpartum Mood Disorders
• Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
• The Effects of Sex Hormones on Cognition and Mood in Older Adults